Work

Faculty Opinions recommendation of Immunogenomic profiling determines responses to combined PARP and PD-1 inhibition in ovarian cancer.

Year: 2020

Type: peer-review

Source: Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature

DOI: 10.3410/f.737595204.793573470

Authors: Ronny Drapkin, Hunter Reavis

Institution: University of Pennsylvania

Language: English

Topic: PARP inhibition in cancer therapy

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4241761284

Cites:

Cited by:

Related to: 10